Navigation Links
Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards

Behavioral Health Pharmacy Management Program improves patient care while

saving Medicaid dollars

INDIANAPOLIS, April 16 /PRNewswire-FirstCall/ -- URAC announced the winners of its inaugural Best Practices in Consumer Empowerment and Protection Awards competition, naming the Missouri Department of Mental Health, Missouri HealthNet, Comprehensive NeuroScience, Inc. and Eli Lilly and Company as Silver Award winners in the Health Information Technology category for the Behavioral Health Pharmacy Management (BPM) program. The program also received an Honorable Mention Award in the Integrated Care Coordination category.

The awards were presented at a black tie gala during URAC's Best Practices in Consumer Empowerment and Protection Conference in Orlando, Fla. During the conference, award finalists presented their model programs to attendees so these best practices can be duplicated in communities across the country. Details on the BPM program are available online at

"A Best Practices Award is a strong signal to the market that an organization places a premium on consumer protection and empowerment," said Alan P. Spielman, URAC's president and CEO. "We are excited about this opportunity to recognize these trailblazers and draw attention to programs that are models for the industry."

How the Program Works

The BPM program evaluates pharmacy claims for all mental health medications to identify prescribing patterns that are inconsistent with evidence-based best practices in standards of care, including research published in medical journals. The program then alerts and educates doctors whose data is inconsistent with these best practices

The program may be tailored to identify several types of care improvement opportunities such as:

-- Duplicative prescribing of medication by different doctors for the same


-- Premature, rapid switching from one medication to another

-- Prescribing above or below recommended dosing levels

-- Patients' failure to refill their medications in a timely manner

Missouri's BPM program has produced positive results. Program studies have shown a 43 percent decrease in hospital admissions for program participants and an overall savings of $7.7 million in Medicaid costs that the state would have incurred in fiscal year 2004.

The program has run in half of states nationwide, resulting in more than 2 million Medicaid patient care improvement interventions.

"Not only do the patients do better, but the doctors are able to provide care more effectively and efficiently," said Joe Parks, M.D., medical director for the Missouri Department of Mental Health. "The partnership is a model for reducing hospitalizations, containing pharmacy costs, improving prescribing practices and maintaining open access to psychiatric medications."

States and CNS work together to identify prescription patterns. Lilly provides financial support for the initiative, and the operation and implementation of the program is done solely by the states and CNS. If a state decides to share data with Lilly, the data is blinded aggregate data that does not contain information about individual patients. In addition, Lilly has received approval and support from the Centers for Medicare & Medicaid Services for these initiatives.

"Just like cancer or diabetes, mental illness is a devastating disease that impacts millions. We believe that funding programs which leverage information, technology and education to improve patient care and efficiencies in the health care system will have a huge beneficial impact on our society," said Jack Bailey, vice president, Lilly.

"At CNS, we work to provide treating physicians with comprehensive information about their patients' treatment histories and the most applicable evidence-based best practice insights from the literature. Armed with the right information, physicians can make better treatment decisions," said John Docherty, M.D., founder and chairman at Comprehensive NeuroScience, Inc. "The Behavioral Health Pharmacy Management program demonstrates how state Medicaid programs can improve patient care while freeing scarce Medicaid dollars for other pressing healthcare needs."

In all, URAC honored 22 winners for excellence among entries from health care management, health information technology, health plan and pharmacy benefit management organizations. Entries were judged by a distinguished panel of industry experts in three categories: consumer decision support, consumer/patient safety and integrated care coordination. Programs were selected as winners for their ability to measurably demonstrate an impact on consumer empowerment and/or protection, as well as their potential for widespread implementation of the program by other organizations.

A complete list of winners of the Best Practices in Consumer Empowerment and Protection Awards may be found at

About Comprehensive NeuroScience, Inc.

Comprehensive NeuroScience, Inc. (CNS) is a national privately-held clinical research company based in White Plains NY. CNS specializes in products and services that enhance the efficiencies of clinical development and use of therapeutic pharmaceuticals for persons with serious mental illnesses. The Care Management Technologies division of CNS, leverages the expertise and scientific breakthroughs for which CNS is known in order to deliver innovative and effective integrated care management solutions focusing on improving quality of care while reducing pharmacy and health care costs for people, payors and the larger community.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at

About URAC

URAC, an independent, nonprofit organization, is well-known as a leader in promoting health care quality through its accreditation and education programs. URAC offers a wide range of quality benchmarking programs and services that keep pace with the rapid changes in the health care system and provide a symbol of excellence for organizations to validate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in establishing meaningful quality measures for the entire health care industry. For more information, visit


(Logo: )

(Logo: )

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Experimental drug shows promise in treating certain lymphomas
2. Experimental Cancer Vaccines Show Promise
3. Developing cancer treatments directed at critical developmental pathway
4. Gourmetceuticals Presents Findings on Science You Can Eat at Experimental Biology 2008
5. College Students Promote Mental Health Awareness During National Stress Out Day
6. Cavities in Children Reduced Over 60 Percent by New Experimental Chewable Mints
7. The Zero Mentality: Is It Good for Infection Control?
8. Get Connected in May and Boost Your Mental Health
9. Mental Health Advocates Rally to Raise the $60
10. Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008
11. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses
Post Your Comments:
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating ... our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment ... day excited to rebuild lives and it’s an honor to have served all of ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/26/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact center ... reliability. , The new Q-Suite 6 platform is based on the latest Java Enterprise ... a specific piece of software for many key components of the suite. Much of ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015 --> ... online. The potential to save costs, improve treatment quality ... from fully exploited as yet. Here, particular emphasis is ... via mobile tablet or directly at the patients, bedside. ... ) -->      (Photo: ...
(Date:11/27/2015)... Research and Markets ( ) has announced the ... report to their offering. ... author the present scenario and growth prospects of the ... market size, the report considers revenue generated from the ... copper IUDs. The report forecasts the global intrauterine devices ...
(Date:11/26/2015)... November 26, 2015 Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Research . --> Clinical Cancer Research . ...
Breaking Medicine Technology: